# ADZENYS XR-ODT
> **NDA204326** · New Drug Application · Sponsor: NEOS THERAPS · Approved 2016-01-27
## Drug
- **FDA Application Number:** NDA204326
- **Application type:** New Drug Application
- **Brand name:** ADZENYS XR-ODT
- **Generic name:** AMPHETAMINE EXTENDED-RELEASE
- **Active ingredients:** AMPHETAMINE
- **Dosage form:** TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NEOS THERAPS
- **Manufacturer:** Neos Therapeutics, LP
- **First approval:** 2016-01-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204326)
---
*AI Analytics · CC0 1.0*